Technology

The round follows a $200 million seed raise earlier this year.

The company will use the funds to invest in AI research and development initiatives.

The feature uses machine learning and heart sensor data to flag signs of hypertension and will roll out to Watch Series 9, 10 and 11 as well as Ultra 2 and 3 by month’s end.

Dr. Erik Langhoff, chief medical officer and consultant for the Bronx Regional Health Information Organization, discusses how the agency is addressing safety and efficacy in AI.

The funding round comes one month after the company announced it secured a $35 million investment.

The aim is to utilize Hippocratic AI's agents to keep patients informed, supportive and connected.

The funds will be used to expand the company's reach with payers and providers, grow its team and for product development.

According to Dr. David K. Butler, Epic emeritus CMIO and clinical informatics leader at Calyx Partners, securing buy-in from clinicians and staff, tracking training and budgeting for post-go-live optimization are essential for lasting EHR adoption.

The company is on track to be live in 10 U.S. states by the end of 2025.

The AirPods Pro 3 will include heart rate sensing, while the Watch Series 11 will come with hypertension detection and a new sleep score.